# FDA Inspection 1304042 - Octapharma plasma - January 21, 2026

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma/40b1062e-e347-4a59-976b-ebcff2f81807
Source feed: FDA_Inspections

> FDA Inspection 1304042 for Octapharma plasma on January 21, 2026. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1304042
- Company Name: Octapharma plasma
- Inspection Date: 2026-01-21
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics

## Related Documents

- [FDA Inspection 1304042 - 2026-01-21](https://www.keypedia.com/records/fda_inspections/octapharma-plasma/722a4618-5b39-4f7a-b879-074343dbdf32)
- [FDA Inspection 1043453 - 2018-03-01](https://www.keypedia.com/records/fda_inspections/octapharma-plasma/0c699aac-78e8-4daf-86bc-7cdfc1c9dee1)
- [FDA Inspection 897806 - 2014-09-29](https://www.keypedia.com/records/fda_inspections/octapharma-plasma/2f312acb-2e37-4dd3-96cc-842f2eb3121e)
- [FDA Inspection 771601 - 2012-02-08](https://www.keypedia.com/records/fda_inspections/octapharma-plasma/39d4fba5-d68f-4002-88c1-0cf936834485)
- [FDA Inspection 676545 - 2010-08-19](https://www.keypedia.com/records/fda_inspections/octapharma-plasma/f29cab5d-732f-4a30-a192-3f8819baae1f)

Company: https://www.keypedia.com/companies/octapharma-plasma/f385edae-f146-46b3-a026-05a0fef8d681